Business Context and Reporting Period
This Form 8-K filing by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) reports on the 2013 Annual Meeting of Stockholders held on June 6, 2013. The company is incorporated in Delaware with principal executive offices in South San Francisco, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Of the 25,416,016 shares of common stock outstanding as of the April 12, 2013 record date, 24,034,822 shares (94.56%) were represented at the meeting. The following matters were voted upon:
- Election of Class III Directors: Samuel D. Colella and Gajus V. Worthington were elected to serve until the 2016 annual meeting. Both nominees received significant support with over 22.8 million votes each.
- Advisory Vote on Executive Compensation: Stockholders approved the compensation of named executive officers for the year ended December 31, 2012, with 22,804,254 votes for and 171,719 votes against. The company will continue to hold this advisory vote annually.
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2013, was ratified with 23,958,329 votes for and 76,493 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirmation of the new Class III directors' tenure until 2016.
- Verification of the annual frequency for executive compensation advisory votes.
- Confirmation that Ernst & Young LLP remains the independent auditor for the 2013 fiscal year.
- Review of the full proxy statement for detailed executive compensation data referenced in the advisory vote.